PL2435021T3 - Zastosowanie połączenia glikozoaminoglikanowego o stałych proporcjach i kompozycji do żucia zawierającej wspomniane połączenie o stałych proporcjach - Google Patents

Zastosowanie połączenia glikozoaminoglikanowego o stałych proporcjach i kompozycji do żucia zawierającej wspomniane połączenie o stałych proporcjach

Info

Publication number
PL2435021T3
PL2435021T3 PL10727845T PL10727845T PL2435021T3 PL 2435021 T3 PL2435021 T3 PL 2435021T3 PL 10727845 T PL10727845 T PL 10727845T PL 10727845 T PL10727845 T PL 10727845T PL 2435021 T3 PL2435021 T3 PL 2435021T3
Authority
PL
Poland
Prior art keywords
fixed combination
glycosaminoglycan
chewable composition
combination
fixed
Prior art date
Application number
PL10727845T
Other languages
English (en)
Inventor
Angelo Pizzoni
Beniamino Palmieri
Original Assignee
Sofar Swiss Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofar Swiss Sa filed Critical Sofar Swiss Sa
Publication of PL2435021T3 publication Critical patent/PL2435021T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL10727845T 2009-05-25 2010-05-25 Zastosowanie połączenia glikozoaminoglikanowego o stałych proporcjach i kompozycji do żucia zawierającej wspomniane połączenie o stałych proporcjach PL2435021T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP09006955 2009-05-25
EP09014212 2009-11-13
PCT/IB2010/001227 WO2010136872A2 (en) 2009-05-25 2010-05-25 Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
EP10727845.9A EP2435021B1 (en) 2009-05-25 2010-05-25 Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination

Publications (1)

Publication Number Publication Date
PL2435021T3 true PL2435021T3 (pl) 2014-03-31

Family

ID=42646250

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10727845T PL2435021T3 (pl) 2009-05-25 2010-05-25 Zastosowanie połączenia glikozoaminoglikanowego o stałych proporcjach i kompozycji do żucia zawierającej wspomniane połączenie o stałych proporcjach

Country Status (7)

Country Link
EP (1) EP2435021B1 (pl)
DK (1) DK2435021T3 (pl)
ES (1) ES2428337T3 (pl)
PL (1) PL2435021T3 (pl)
PT (1) PT2435021E (pl)
SM (1) SMT201300118B (pl)
WO (1) WO2010136872A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015125120A1 (en) * 2014-02-21 2015-08-27 Idi Integratori Dietetici Italiani S.R.L. New chewable composition
DE202014008682U1 (de) 2014-07-11 2015-08-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Magenbeschwerden
EP3056195A1 (en) * 2015-02-13 2016-08-17 Vision:Organic GmbH Compositions comprising hyaluronic acid and beta-glucan for topical applications in oral cavity
EA037070B9 (ru) * 2015-10-01 2021-03-29 Афарм С.Р.Л. Комбинация гликозаминогликанов и антацидного агента и содержащая ее композиция
IT201600101413A1 (it) 2016-10-10 2018-04-10 Sofar Swiss S A Composizione liquida per uso nel trattamento del reflusso gastroesofageo
IT201700108526A1 (it) 2017-09-28 2019-03-28 Alfasigma Spa Composizioni orali per il trattamento del refluso gastroesofageo.
IT201700124424A1 (it) * 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali
IT201700124434A1 (it) * 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali per uso nel trattamento di una sottopopolazione di pazienti GERD.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452138A (en) * 1964-08-26 1969-06-24 Bristol Myers Co Urea-containing chewable antacid tablets
AU555747B2 (en) 1983-08-09 1986-10-09 Cilco Inc. Chondroitin sulfate and sodium hyaluronate composition
JPS6147418A (ja) * 1984-08-13 1986-03-07 Seikagaku Kogyo Co Ltd ヒアルロン酸含有胃粘膜保護剤
DK505588D0 (da) * 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
GB9910212D0 (en) 1999-05-05 1999-06-30 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
IT1318649B1 (it) * 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
US6924273B2 (en) * 2000-10-03 2005-08-02 Scott W. Pierce Chondroprotective/restorative compositions and methods of use thereof
US20080003258A1 (en) 2002-10-16 2008-01-03 Marcum Frank D Composition and Method for Treating Rheumatoid Arthritis
US7504387B2 (en) 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
KR20060040329A (ko) * 2004-11-05 2006-05-10 나건 내시경을 통하여 도포 가능한 체내 지혈제 및 그 도포 방법

Also Published As

Publication number Publication date
DK2435021T3 (da) 2013-10-07
ES2428337T3 (es) 2013-11-07
EP2435021B1 (en) 2013-07-03
WO2010136872A2 (en) 2010-12-02
WO2010136872A3 (en) 2011-05-26
SMT201300118B (it) 2013-11-08
PT2435021E (pt) 2013-09-30
EP2435021A2 (en) 2012-04-04

Similar Documents

Publication Publication Date Title
HRP20180497T1 (hr) Antimikrobni pripravci i odgovarajući postupci njihove upotrebe
IL249747A0 (en) Antibacterial preparation for oral administration
IL239997A (en) Certain triazolopyridines and certain triazolopyrazines and their preparations and uses
HK1243596A1 (zh) 作為鋅螯合劑的薑黃素類似物和其用途
IL218016A0 (en) Pharmaceutical compositions comprising bi-1356 and metformin
GB0905290D0 (en) Multilayer compositions and dressings
EP2412789A4 (en) LUBRICANT COMPOSITION AND ITS USE
EP2389071A4 (en) ANTIMICROBIAL COMPOSITIONS ELIMINATING BIOPELLICLES AND THEIR APPLICATIONS
PL2435021T3 (pl) Zastosowanie połączenia glikozoaminoglikanowego o stałych proporcjach i kompozycji do żucia zawierającej wspomniane połączenie o stałych proporcjach
PT2296670E (pt) Utilização oral de glicosaminoglicana e composições
IL211204A0 (en) Mucoadherents compositions and their use
EP2460405A4 (en) ANTIBACTERIAL AGENT
HK1171963A1 (en) Dentrifice composition
IL219552A0 (en) Synergistic antiviral composition and use thereof
GB0902429D0 (en) Compositions and their use
GB0902173D0 (en) Compounds and their use
GB0922510D0 (en) Compound and use
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
GB0909792D0 (en) Composition and uses thereof
GB0902812D0 (en) Composition and use
GB0906042D0 (en) Nalmefene compositions and their therapeutic use
GB0906044D0 (en) Nalmefene compositions and their therapeutic use
GB0906045D0 (en) Nalmefene compositions and their therapeutic use
GB0906043D0 (en) Nalmefene compositions and their therapeutic use
GB0906046D0 (en) Nalmefene compositions and their therapeutic use